Apple 10271 Published by Bob 0

Forget the oil crisis, the dollar swoon or the housing bust. The biggest worry for many in the technology and investment community is the health of Apple's iconic founder and chief executive Steve Jobs. The 53-year-old legend underwent successful surgery for pancreatic cancer about four years ago, and rumors of a relapse started swirling last month when he looked gaunt, pale and far from his usual exuberant self.

Report: Steve Jobs' Health Issues Overblown

Apple 10271 Published by Bob 0

The towering role of Steve Jobs at Apple was underscored this week when concerns about his health contributed to a sudden plunge in the company's stock. Apple shares recovered significantly on Tuesday, but Wall Street's worries spotlight the enormous importance of Jobs to Apple and spur questions about the company's responsibility to address the recurring rumors regarding his health.

Conjecture About Jobs' Health Weighs Down Apple Stock

Apple 10271 Published by Bob 0

By most measures, Apple had a banner third quarter. It beat Wall Street's expectations for earnings, posting revenue of $7.46 billion and net quarterly profit of $1.07 billion, or $1.19 per diluted share. These results compare with revenue of $5.41 billion and net quarterly profit of $818 million, or $0.92 per diluted share, in the year-ago quarter.

Cautious Guidance Nicks Apple